Affordable Access

Therapy with factor IX concentrate resulting in DIC and thromboembolic phenomena.

Authors
  • Campbell, E W
  • Neff, S
  • Bowdler, A J
Type
Published Article
Journal
Transfusion
Publication Date
Jan 01, 1978
Volume
18
Issue
1
Pages
94–97
Identifiers
PMID: 625789
Source
Medline
License
Unknown

Abstract

The development of subclinical DIC in a patient with factor IX hemophilia receiving concentrate replacement therapy during surgery is discussed with respect to pertinent laboratory features. Subsequent thromboembolic phenomena are presented in the context of current literature. Of significance is the failure of heparin given with the factor IX concentrate to prevent DIC. The value of adequate laboratory monitoring during therapy is stressed.

Report this publication

Statistics

Seen <100 times